Suma Krishnan - President, R&D, Director, 10%+ Owner at Krystal Biotech, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
President, R&D, Director, 10%+ Owner
Stock Symbol
KRYS on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
All Insider Reports
All Insider Reports

Suma Krishnan - trading volume in the past year for Krystal Biotech, Inc.

Holdings reported by Suma Krishnan for Krystal Biotech, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 1.41M $314M $222.38 Dec 4, 2025 Direct
Common Stock 1.48M $297M $201.21 Dec 5, 2025 By Spouse
Common Stock 90K $18.1M $201.21 Dec 4, 2025 By SMK Trust
Common Stock 50K $10.1M $201.21 Dec 4, 2025 By Krishnan Family Trust
Performance Stock Units 22.5K $3.97M $176.39 Feb 28, 2025 Direct Common Stock
Restricted Stock Units 16K $2.82M $176.39 Feb 28, 2025 Direct Common Stock
Stock Option (Right to Buy) 25K $2.05M $81.91 Feb 28, 2025 Direct Common Stock

Transactions reported by Suma Krishnan for Krystal Biotech, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.